ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Mediplantex National Pharmaceutical JSC ?
1
Poor Management Efficiency with a low ROE of 4.86%
- The company has been able to generate a Return on Equity (avg) of 4.86% signifying low profitability per unit of shareholders funds
2
Company has a low Debt to Equity ratio (avg) at times
3
Positive results in Dec 25
- RAW MATERIAL COST(Y) Fallen by -10.34% (YoY)
- DEBTORS TURNOVER RATIO(HY) Highest at 5.47 times
- NET SALES(Q) Highest at VND 117,611.85 MM
4
With ROE of 3.62%, it has a fair valuation with a 0.87 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -23.02%, its profits have fallen by -28.7%
- At the current price, the company has a high dividend yield of 5.3
5
Below par performance in long term as well as near term
- Along with generating -23.02% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Mediplantex National Pharmaceutical JSC should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Mediplantex National Pharmaceutical JSC for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Mediplantex National Pharmaceutical JSC
-100.0%
-0.51
39.57%
Vietnam VN Ho Chi Minh Index
28.61%
1.16
25.30%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-6.78%
EBIT Growth (5y)
-5.24%
EBIT to Interest (avg)
3.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
1.09
Tax Ratio
21.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.88%
ROE (avg)
4.86%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
0.87
EV to EBIT
16.83
EV to EBITDA
12.72
EV to Capital Employed
0.88
EV to Sales
0.80
PEG Ratio
NA
Dividend Yield
5.31%
ROCE (Latest)
5.21%
ROE (Latest)
3.62%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -10.34% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 5.47 times
NET SALES(Q)
Highest at VND 117,611.85 MM
OPERATING PROFIT(Q)
Highest at VND 8,426.2 MM
PRE-TAX PROFIT(Q)
Highest at VND 8,366.82 MM
NET PROFIT(Q)
Highest at VND 6,139.3 MM
EPS(Q)
Highest at VND 495
-9What is not working for the Company
NET SALES(9M)
At VND 291,651.53 MM has Grown at -13.84%
INTEREST COVERAGE RATIO(Q)
Lowest at 649.87
CASH AND EQV(HY)
Lowest at VND 60,101.83 MM
DIVIDEND PER SHARE(HY)
Lowest at VND 5.47
INTEREST(Q)
Highest at VND 1,296.6 MM
Here's what is working for Mediplantex National Pharmaceutical JSC
Net Sales
At VND 117,611.85 MM has Grown at 32.38%
over average net sales of the previous four periods of VND 88,847.36 MMMOJO Watch
Near term sales trend is very positive
Net Sales (VND MM)
Pre-Tax Profit
At VND 8,366.82 MM has Grown at 117.05%
over average net sales of the previous four periods of VND 3,854.77 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (VND MM)
Net Profit
At VND 6,139.3 MM has Grown at 104.04%
over average net sales of the previous four periods of VND 3,008.91 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (VND MM)
Net Sales
Highest at VND 117,611.85 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (VND MM)
Operating Profit
Highest at VND 8,426.2 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (VND MM)
Pre-Tax Profit
Highest at VND 8,366.82 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (VND MM)
Net Profit
Highest at VND 6,139.3 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (VND MM)
EPS
Highest at VND 495
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (VND)
Debtors Turnover Ratio
Highest at 5.47 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -10.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Mediplantex National Pharmaceutical JSC
Interest
At VND 1,296.6 MM has Grown at 133.29%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)
Interest Coverage Ratio
Lowest at 649.87
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
Highest at VND 1,296.6 MM
in the last five periods and Increased by 133.29% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)
Cash and Eqv
Lowest at VND 60,101.83 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Dividend per share
Lowest at VND 5.47
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (VND)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
